Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.21 (
beta-glucosidase
)
3,280
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, different mole fractions of pure Thermomonospora fusca E(5) and E(3), plus Trichoderma reesei CBHI were studied for reducing sugar production at 2 h, degree of synergism, and cellulose binding. In addition, the effects of introducing the Caldocellum saccharolyticum
beta-glucosidase
into this cellulase system were investigated. The cellulases used were purified to homogeneity.
Avicel PH
102 (4% w/w solution in 0.05 sodium acetate pH 5.5 buffer) was the substrate. Reactions were run at 50 degrees C for 2 h using total cellulase concentrations of 8.3 or 12.2 microM. A bimixture of T. fusca E(3) and T. reesei CBHI was very effective in hydrolyzing microcrystalline cellulose (9.1% conversion). The addition of endoglucanase E(5) to the mixture only increased conversion to 9.8%. However, when both E(5) and
beta-glucosidase
were added, conversion increased to 14%. It was also observed that increasing total cellulase concentration beyond 8.3 muM did little to increase percent conversion of cellulose into glucose. The results of the binding studies indicate no competition for binding sites between the endo- and exocellulases.
...
PMID:Engineering cellulase mixtures by varying the mole fraction of Thermomonospora fusca E5 and E3, Trichoderma reesei CBHI, and Caldocellum saccharolyticum beta-glucosidase. 1861 29
